Dale A. Sander - 16 Nov 2025 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role: CFO and Chief Corp. Deve. Off.
Signature: /s/ Dale A. Sander
Issuer symbol: HUMA
Transactions as of: 16 Nov 2025
Net transactions value: $0
Form type: 4
Filing time: 17 Nov 2025, 17:52:29 UTC
Previous filing: 14 Apr 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Sander Dale A.	CFO and Chief Corp. Deve. Off.	2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM	/s/ Dale A. Sander	17 Nov 2025	0001878193

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HUMA	Common Stock	Award	$0	+311,100	+15555%	$0.000000	313,100	16 Nov 2025	Direct	F1
holding	HUMA	Common Stock						40,600	16 Nov 2025	By spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted restricted stock units (RSUs), which represent a contingent right to receive one share of Common Stock for each RSU. The first 50% of the RSUs will vest on May 15, 2026, after which the remaining 50% of the RSUs will vest on May 15, 2027.